Amarin Corp Plc (AMRN)

[IgnoranceIsBliss]

This statement is absurd. It reflects a lemonade stand understanding of economics:

"More specifically, the Court finds that Vascepa is a commercial success even though it has not yet turned a profit"

Amarin has not yet turned a profit. Vascepa has been wildly profitable. The drug, in its narrow MARINE indication, essentially funded a half-billion dollar 6-year global clinical trial.

If it weren't for the costs of REDUCE-IT, Amarin would have been profitable since 2017. Gross margin on Vascepa exceeded SG&A excluding R&D for 2017, and SG&A includes many expenses that wouldn't occur if all Amarin were doing was selling the MARINE indication.

Judge Du thinks Vascepa is a company. That's just great.